Winhycare Pharma · Research use only
GLP-2 and guanylate cyclase-C agonist peptides used in gastrointestinal research. Research-grade material is not the approved medicinal product.
CAS 851199-59-2 · 1526.74 g/mol
guanylate cyclase-C (GC-C) agonist. Approved as an active ingredient by major regulators including the US FDA (first approved 2012) and the EMA for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.
CAS 197922-42-2 · 3752.13 g/mol
GLP-2 analogue. Approved as an active ingredient by major regulators including the US FDA (December 2012) and the EMA / European Commission (August 2012) for the treatment of adults and children with short bowel syndrome who are dependent on parenteral support.
| Peptide | CAS | Molecular weight | Sequence | Purity |
|---|---|---|---|---|
| Linaclotide | 851199-59-2 | 1526.74 g/mol | 14 amino acids, cyclised by three intramolecular disulfide bridges | >99% |
| Teduglutide | 197922-42-2 | 3752.13 g/mol | 33 amino acids (Gly substituted for Ala at position 2 for DPP-4 resistance) | >99% |
Research use only. Research use only. Not for human or veterinary use, and not for use in food, drugs, medical devices or cosmetics. Buyers are responsible for complying with the import and use regulations of their country.
Linaclotide, Teduglutide, each at >99% purity for research use only.
No. They are supplied for laboratory research use only and are not for human or veterinary use. We do not provide dosing or usage advice.
Material is supplied with QC documentation. Tell us in your enquiry what your lab or quality team needs.
Yes. Include the quantity in your enquiry; bulk and distributor quantities are quoted on request.
Products & services
Guides
